BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $5.493B (100.0% shares, 0.0% debt)

Holdings (5)

SGRY SURGERY PARTNERS INC 36.6%

Value $2.008B Shares 58,248,249 Share Price $34.47 Est. Cost/Share — Unrealized @ Report Date —

— DIVERSEY HLDGS LTD 34.9%

Value $1.917B Shares 236,983,211 Share Price $8.09 Est. Cost/Share — Unrealized @ Report Date —

— CEREVEL THERAPEUTICS HLDNG I 26.9%

Value $1.479B Shares 60,632,356 Share Price $24.39 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 1.5%

Value $84.86M Shares 81,600,880 Share Price $1.04 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.1%

Value $4.566M Shares 2,890,000 Share Price $1.58 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
SGRY	SURGERY PARTNERS INC	58,248,249	$2.008B	36.6%	$34.47	—	—	COM	86881A100
—	DIVERSEY HLDGS LTD	236,983,211	$1.917B	34.9%	$8.09	—	—	ORD SHS	G28923103
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1.479B	26.9%	$24.39	—	—	COM	15678U128
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$84.86M	1.5%	$1.04	—	—	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$4.566M	0.1%	$1.58	—	—	COM CL A	00791N102